Overview
- 283 inspections across 257 sites are on record.
- 282 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
283
Sites
257
Observations
282
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biomedical Research Models, Inc. d/b/a Biomere | 29 May 2026 | Biologics | On file |
| Giuseppe Plazzi, M.D. | 30 Apr 2026 | Human Drugs | |
| Takeda Pharmaceuticals, Inc. | 10 Apr 2026 | Human Drugs | |
| Peter R. Movilla, MD | 19 Mar 2026 | Medical Devices & Rad Health | On file |
| Marek Smilowski, MD | 6 Mar 2026 | Human Drugs |
Sites inspected
Biomedical Research Models, Inc. d/b/a BiomereWorcester, United States1 insp.
Giuseppe Plazzi, M.D.Bologna, Italy1 insp.
Takeda Pharmaceuticals, Inc.Cambridge, United States1 insp.
Peter R. Movilla, MDNewton Lower Falls, United States1 insp.
Marek Smilowski, MDKatowice, Poland1 insp.
Co-investigators
Investigators who share inspections with this person.
Meredith L Miller6 shared
Matthew C Watson4 shared
Rory Geyer4 shared
Michael P Anthony3 shared
Michelle M Noe Varga3 shared
Agata E Libera2 shared
John L Zaccone2 shared
Karen M Kondas2 shared
Jamie S Mathews2 shared
Lorayne A Mcguinness2 shared
Full investigator report
Get the verbatim findings behind Kent A Conforti's 282 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site